Received Aug 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 3 | U8314AA | IM / RL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 3 | LJ5282 | IM / LL |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 3 | 2142099 | PO / MO |
Approx 1-2 minutes after administration, patient noted to have perioral cyanosis. Emergent clinic response called and responded within 10-15 seconds. Patient noted to perioral cyanosis, not crying, not sleepy, in mother's arms. Patient placed on exam bed, stimulated with chest rub and started crying. Placed on pulse ox and saturating at 94-95%. Noted rhonchi bilaterally on exam. Given saline nebulizer. Patient normalized with clear lung sounds and pulse ox 99-100% within 3 minutes. Observed for additional 15 minutes without concerns. Mother reported patient woken from sleep just prior to vaccine administration.
None reported
Concern for mild tracheo or laryngomalacia; patient growing well and meeting milestones
None
None